Us2.ai’s Post

🎉 Exciting News from Us2.ai at #EuroEcho2024! 🎉 📣 Late-Breaking Science at EuroEcho–Imaging 2024 in Berlin! Presenting latest advances in the field of Cardiac Amyloidosis with Us2.ai. Join us from 11-13 December 2024 to explore how our AI innovations are reshaping the diagnosis and monitoring of Cardiac Amyloidosis. These groundbreaking studies showcase the power of Us2.ai to revolutionize patient care. 🌟 You won’t want to miss it! 🌟 Late Breaking Science: A fully automated machine learning algorithm to track disease progression in ATTR-CM 🗣️ Lucia Venneri , MD, PhD, Royal Free Hospital, London (UK) 🗓️ Friday, 13 December 2024 🕒 12:18 PM CET (session starts at 11:30am) 📍 Brahms Diagnosis of cardiac amyloidosis on echocardiography using artificial intelligence: a multicentre international development and validation study 🗣️ Adam Ioannou, MBBS, BSc, Royal Free Hospital, London (UK) 🗓️ Friday, 13 December 2024 🕒 12:30 PM CET (session starts at 11:30am) 📍 Brahms #EuroEcho2024 #AIinHealthcare #Echocardiography #CardiovascularInnovation #Cardiology #Echo #AIEcho #Amyloid #LateBreakingScience #CardiacAmyloidosis #PatientsFirst

  • diagram
Christine Gouillard

Head, Medical Liaison & Education

1w

A much awaited reveal of Us2.ai Cardiac Amyloidosis unique solution !

To view or add a comment, sign in

Explore topics